CAG
Crestwood Advisors Group Portfolio holdings
AUM
$5.58B
This Quarter Return
+2.28%
1 Year Return
+14.63%
3 Year Return
+71.56%
5 Year Return
+115.62%
10 Year Return
+272.08%
AUM
$2.27B
AUM Growth
+$2.27B
(+3%)
Cap. Flow
+$32.2M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
26.99%
Holding
261
New
19
Increased
108
Reduced
88
Closed
4
Top Buys
| 1 |
Zoetis
ZTS
|
$16.6M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$5.63M |
| 3 |
Sensata Technologies
ST
|
$5.31M |
| 4 |
Philip Morris
PM
|
$4.92M |
| 5 |
Mastercard
MA
|
$4.56M |
Top Sells
| 1 |
Union Pacific
UNP
|
$15.3M |
| 2 |
Workday
WDAY
|
$5.36M |
| 3 |
Wells Fargo
WFC
|
$4.56M |
| 4 |
Trade Desk
TTD
|
$4.38M |
| 5 |
Starbucks
SBUX
|
$3.97M |
Sector Composition
| 1 | Financials | 17.96% |
| 2 | Technology | 16.75% |
| 3 | Healthcare | 10.45% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Consumer Staples | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSTX
251
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $53K | ﹤0.01% |
15,316
| – | – |
|
252
Nokia
NOK
$23.5B
| $51K | ﹤0.01% |
10,000
-4,000
| -29% | -$20.4K |
|
253
Daktronics
DAKT
$832M
| $41K | ﹤0.01% |
40,989
| – | – |
|
|
PTN
254
DELISTED
Palatin Technologies
PTN
| $23K | ﹤0.01% |
25,000
| – | – |
|
255
Perspective Therapeutics
CATX
$250M
| $18K | ﹤0.01% |
54,824
| – | – |
|
|
CFRX
256
DELISTED
ContraFect Corporation
CFRX
| $5K | ﹤0.01% |
13,500
| – | – |
|
257
Bristol-Myers Squibb
BMY
$96.6B
| – | – |
-6,075
| Closed | -$276K |
|
258
Sanofi
SNY
$122B
| – | – |
-5,813
| Closed | -$252K |
|
259
Viridian Therapeutics
VRDN
$1.58B
| – | – |
-12,000
| Closed | -$25K |
|
|
260
Workday
WDAY
$61.9B
| – | – |
-26,046
| Closed | -$5.36M |
|